https://tevogenbio.com/press-release/ 2026-06-09T20:04:03+00:00 https://tevogenbio.com/press-release/tevogen-bio-to-study-potential-use-of-its-t-cell-technology-in-epstein-barr-virus-and-multiple-sclerosis/ 2022-02-07T16:17:12+00:00 https://tevogenbio.com/wp-content/uploads/2022/02/Download-PDF.png https://tevogenbio.com/press-release/tevogen-bio-appoints-yale-public-health-dean-dr-sten-h-vermund-preeminent-global-expert-in-covid-19-and-infectious-disease-epidemiology-to-its-innovation-and-public-health-advisory-council/ 2022-02-07T16:17:51+00:00 https://tevogenbio.com/wp-content/uploads/2022/02/Download-PDF.png https://tevogenbio.com/press-release/tevogen-bio-announces-positive-safety-data-from-second-cohort-in-ongoing-proof-of-concept-clinical-trial-of-tvgn-489-its-investigational-t-cell-therapy-for-treatment-of-covid-19-in-high-risk-patients/ 2022-02-07T16:18:33+00:00 https://tevogenbio.com/wp-content/uploads/2022/02/Download-PDF.png https://tevogenbio.com/press-release/tevogen-bio-accelerates-growth-with-new-corporate-hub-to-accommodate-its-expanding-operations/ 2022-02-07T20:55:34+00:00 https://tevogenbio.com/wp-content/uploads/2022/02/Download-PDF.png https://tevogenbio.com/wp-content/uploads/2022/02/15KCJP_15IndeBlvdWarrenNJ_05.jpg https://tevogenbio.com/press-release/tevogen-bio-appoints-prominent-industry-leader-susan-podlogar-to-the-companys-corporate-advisory-board/ 2022-03-02T18:48:19+00:00 https://tevogenbio.com/wp-content/uploads/2022/02/Download-PDF.png https://tevogenbio.com/wp-content/uploads/2022/03/Podlogar_Susan_headshot_new.jpg https://tevogenbio.com/press-release/tevogen-bio-expands-executive-leadership-team-to-accelerate-operational-growth-and-commercial-readiness/ 2022-04-06T15:23:26+00:00 https://tevogenbio.com/wp-content/uploads/2022/02/Download-PDF.png https://tevogenbio.com/wp-content/uploads/2022/04/Stephen-Chen-and-Sadiq-Khan.png https://tevogenbio.com/press-release/tevogen-bio-expands-research-and-development-capacity-at-cic-philadelphia-to-accommodate-its-expanding-product-portfolio/ 2022-05-03T22:34:27+00:00 https://tevogenbio.com/wp-content/uploads/2022/02/Download-PDF.png https://tevogenbio.com/wp-content/uploads/2022/05/3675-Market-CIC.jpg https://tevogenbio.com/press-release/tevogen-bio-initiates-final-dose-level-in-proof-of-concept-clinical-trial/ 2022-06-08T15:47:21+00:00 https://tevogenbio.com/wp-content/uploads/2022/02/Download-PDF.png https://tevogenbio.com/press-release/tevogen-bio-appoints-distinguished-clinician-and-former-matheny-president-and-ceo-dr-kendell-r-sprott-to-corporate-advisory-board/ 2022-06-30T18:13:59+00:00 https://tevogenbio.com/wp-content/uploads/2022/02/Download-PDF.png https://tevogenbio.com/wp-content/uploads/2022/06/Bio-Kendell-Sprott.png https://tevogenbio.com/press-release/tevogen-bio-establishes-philadelphia-rd-center-to-expedite-product-development-in-oncology-neurology-and-virology/ 2022-06-30T18:24:56+00:00 https://tevogenbio.com/wp-content/uploads/2022/02/Download-PDF.png https://tevogenbio.com/wp-content/uploads/2022/06/Wanamaker_Photo.jpg https://tevogenbio.com/press-release/tevogen-bio-appoints-acclaimed-oncologist-and-immunotherapy-expert-neal-flomenberg-m-d-as-chief-scientific-officer-and-global-head-of-rd/ 2022-07-11T23:46:06+00:00 https://tevogenbio.com/wp-content/uploads/2022/02/Download-PDF.png https://tevogenbio.com/wp-content/uploads/2022/07/Neal-Flomenberg.jpg https://tevogenbio.com/press-release/tevogen-bio-appoints-three-prominent-healthcare-leaders-to-its-board-of-directors/ 2022-08-18T21:15:42+00:00 https://tevogenbio.com/wp-content/uploads/2022/02/Download-PDF.png https://tevogenbio.com/wp-content/uploads/2022/08/Feike-Podlogar-Goh.png https://tevogenbio.com/press-release/tevogen-bio-appoints-esteemed-global-safety-management-expert-victor-sordillo-to-its-corporate-advisory-board/ 2022-08-31T19:42:27+00:00 https://tevogenbio.com/wp-content/uploads/2022/02/Download-PDF.png https://tevogenbio.com/wp-content/uploads/2022/08/Bio-Vic-Sordillo-1.png https://tevogenbio.com/press-release/tevogen-bio-announces-positive-safety-results-upon-completion-of-patient-enrollment/ 2022-09-12T19:06:37+00:00 https://tevogenbio.com/wp-content/uploads/2022/02/Download-PDF.png https://tevogenbio.com/press-release/tevogen-bio-expresses-gratitude-for-2023-nobel-peace-prize-nomination/ 2022-10-12T20:13:57+00:00 https://tevogenbio.com/wp-content/uploads/2022/02/Download-PDF.png https://tevogenbio.com/wp-content/uploads/2022/10/PR-Headshot-Patton-Saadi.png https://tevogenbio.com/press-release/tevogen-bio-ceo-ryan-saadi-and-chief-scientific-officer-neal-flomenberg-share-white-house-concerns/ 2022-10-27T17:58:34+00:00 https://tevogenbio.com/wp-content/uploads/2022/02/Download-PDF.png https://tevogenbio.com/press-release/tevogen-bio-to-study-therapeutic-potential-of-its-investigational-covid-19-t-cell-therapy-in-long-covid/ 2022-11-22T18:47:16+00:00 https://tevogenbio.com/wp-content/uploads/2022/02/Download-PDF.png https://tevogenbio.com/press-release/tevogen-bio-to-develop-t-cell-therapies-for-treatment-of-epstein-barr-virus-related-cancers-and-multiple-sclerosis/ 2022-12-01T19:40:34+00:00 https://tevogenbio.com/wp-content/uploads/2022/02/Download-PDF.png https://tevogenbio.com/press-release/tevogen-bio-to-study-its-investigational-covid-19-t-cell-therapy-in-immunocompromised-patients-who-are-unable-to-benefit-from-currently-available-prevention-or-treatment-options/ 2022-12-07T20:41:02+00:00 https://tevogenbio.com/wp-content/uploads/2022/02/Download-PDF.png https://tevogenbio.com/press-release/tevogen-bio-announces-positive-proof-of-concept-clinical-trial-results/ 2023-01-23T22:57:35+00:00 https://tevogenbio.com/wp-content/uploads/2022/02/Download-PDF.png https://tevogenbio.com/press-release/tevogen-bio-cso-to-discuss-investigational-t-cell-therapy-at-nola-conference-focused-on-long-covid-and-covid-related-cancer-risk-alongside-leading-oncology-experts/ 2023-05-01T20:56:47+00:00 https://tevogenbio.com/wp-content/uploads/2022/02/Download-PDF.png https://tevogenbio.com/press-release/tevogen-bio-expresses-gratitude-as-ceo-is-named-recipient-of-boy-scouts-of-america-distinguished-citizen-award/ 2023-05-16T02:05:02+00:00 https://tevogenbio.com/wp-content/uploads/2022/02/Download-PDF.png https://tevogenbio.com/press-release/tevogen-bio-further-strengthens-ip-portfolio-with-additional-patent-for-method-of-preparing-its-investigational-sars-cov-2-specific-t-cell-therapy/ 2023-06-08T22:30:19+00:00 https://tevogenbio.com/wp-content/uploads/2022/02/Download-PDF.png https://tevogenbio.com/press-release/tevogen-bio-to-become-publicly-listed-on-nyse-via-business-combination-with-semper-paratus-acquisition-corporation/ 2023-06-30T22:17:00+00:00 https://tevogenbio.com/wp-content/uploads/2023/06/SP.png https://tevogenbio.com/wp-content/uploads/2023/06/Tevogen.png https://tevogenbio.com/press-release/tevogen-bio-to-become-publicly-listed-on-nyse-via/ 2023-06-30T23:28:41+00:00 https://tevogenbio.com/wp-content/uploads/2023/06/SP.png https://tevogenbio.com/wp-content/uploads/2023/06/Tevogen.png https://tevogenbio.com/press-release/tevogen-bio-welcomes-victor-sordillo-renowned-global-safety-management-expert-to-its-board-of-directors/ 2023-07-25T17:36:13+00:00 https://tevogenbio.com/press-release/semper-paratus-acquisition-corporation-files-registration-statement-on-form-s-4-in-connection-with-proposed-business-combination-with-tevogen-bio-inc/ 2023-09-14T22:46:22+00:00 https://tevogenbio.com/wp-content/uploads/2023/06/SP.png https://tevogenbio.com/wp-content/uploads/2023/06/Tevogen.png https://tevogenbio.com/press-release/tevogen-bio-congratulates-innovation-and-public-health-advisory-board-chairperson-professor-sten-vermund-on-being-elected-to-serve-as-president-of-the-global-virus-network/ 2023-10-27T18:13:17+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/wp-content/uploads/2023/09/Sten-Vermund-PR.png https://tevogenbio.com/press-release/tevogen-bio-introduces-tevogen-ai/ 2023-10-27T18:26:13+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-AI-Logo.svg https://tevogenbio.com/press-release/tevogen-bio-appoints-it-expert-and-leader-mittul-mehta-as-chief-information-officer-and-head-of-tevogen-ai-initiative/ 2023-10-27T18:49:44+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/wp-content/uploads/2023/10/Mittul-Mehta-Headshot-PR.png https://tevogenbio.com/press-release/tevogen-bio-expands-presence-in-rapidly-emerging-field-of-biotechnology-ai-files-patent-applications-related-to-ai-driven-t-cell-target-identification-and-receptor-engagement/ 2024-01-03T22:52:57+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-inc-and-semper-paratus-acquisition-corporation-announce-effectiveness-of-registration-statement-for-business-combination/ 2024-01-05T21:59:02+00:00 https://tevogenbio.com/wp-content/uploads/2023/06/SP.png https://tevogenbio.com/wp-content/uploads/2023/06/Tevogen.png https://tevogenbio.com/press-release/semper-paratus-acquisition-corporation-announces-anticipated-listing-of-tevogen-bio-holdings-inc-on-nasdaq/ 2024-01-29T20:08:00+00:00 https://tevogenbio.com/wp-content/uploads/2023/06/SP.png https://tevogenbio.com/wp-content/uploads/2023/06/Tevogen.png https://tevogenbio.com/press-release/cell-therapy-company-tevogen-bio-holdings-inc-nasdaq-tvgn-rings-opening-bell-at-nasdaq-exchange-on-february-15th-2024-begins-public-trading-on-the-open-market/ 2024-02-19T20:27:40+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/wp-content/uploads/2024/02/mo_021524_highres8.jpg https://tevogenbio.com/press-release/tevogen-bio-announces-8-million-equity-investment/ 2024-02-19T20:28:49+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-is-looking-forward-to-closing-its-transaction-with-semper-paratus/ 2024-02-19T20:29:01+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-appoints-globally-prominent-physicist-specializing-in-space-biology-covid-19-and-ai-democratization-afshin-beheshti-to-advisory-board/ 2024-02-19T20:29:15+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/wp-content/uploads/2024/01/Afshin-Beheshti.jpg https://tevogenbio.com/press-release/cell-therapy-company-tevogen-bio-holdings-inc-prepares-to-launch-crucial-genetic-predisposition-study-in-preparation-to-investigate-the-potential-of-tvgn-489-to-address-critical-unmet-need-for-long-c/ 2024-02-21T18:49:34+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/mittul-mehta-head-of-tevogens-artificial-intelligence-initiative-tevogen-ai-emphasizes-importance-of-proactive-talent-development-for-biopharmaceutical-sector-to-allow-rapid-adoption-of-ai/ 2024-02-27T22:01:52+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/wp-content/uploads/2024/02/Tevogen-AI-Logo.png https://tevogenbio.com/wp-content/uploads/2024/02/MIttul-at-Yale.png https://tevogenbio.com/press-release/tevogen-bio-holdings-congratulates-its-board-member-and-esteemed-global-safety-management-expert-victor-sordillo-on-his-appointment-as-managing-director-of-risk-advisory-services-at-verita/ 2024-03-19T20:23:57+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-reports-its-investigational-sars-cov-2-specific-t-cell-therapy-tvgn-489-retains-activity-against-the-dominant-jn-1-variant/ 2024-03-21T00:11:59+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-reports-series-a-1-preferred-stock-investment/ 2024-04-01T16:05:27+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-appoints-tapan-v-shah-as-head-of-investor-relations-and-corporate-development/ 2024-04-03T16:12:42+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/wp-content/uploads/2024/04/Tapan-Shah-Headshot-4288160608-e1712117794919.png https://tevogenbio.com/press-release/tevogen-bios-chief-scientific-officer-speaks-on-the-harnessing-of-cytotoxic-t-lymphocytes-ctls-to-target-cancers/ 2024-04-12T17:54:02+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-ceo-highlights-expected-reporting-of-a-94-9-million-liability-elimination-ai-initiative-and-leadership-appointments/ 2024-04-26T14:04:32+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-announces-full-year-2023-financial-results-and-upcoming-operational-objectives/ 2024-05-01T13:20:32+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-announces-up-to-50-million-in-financing-to-further-advance-operational-objectives/ 2024-05-16T18:47:23+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-appoints-former-police-chief-fbi-national-academy-graduate-william-keane-as-vice-president-of-strategic-initiatives/ 2024-05-17T15:34:50+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/wp-content/uploads/2024/05/William-Keane.png https://tevogenbio.com/press-release/tevogen-bio-reports-first-quarter-2024-financial-results/ 2024-05-29T19:41:16+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-confirms-ongoing-efficacy-of-tvgn-489-its-investigational-allogeneic-off-the-shelf-immunotherapy-against-dominant-flirt-strains-of-sars-cov-2/ 2024-06-07T22:29:02+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-expresses-gratitude-to-patients-first-responders-elected-officials-and-members-of-the-united-states-congress-for-attending-its-inaugural-post-public-listing-social-engagement-event/ 2024-06-08T00:19:03+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/wp-content/uploads/2024/06/Tevogen-Bio-Social-Engagement-Event.jpg https://tevogenbio.com/press-release/tevogen-bio-enters-into-agreement-for-up-to-50-million-in-financing-to-advance-rd-and-clinical-development-efforts/ 2024-06-12T16:00:30+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-set-to-join-russell-3000-index/ 2024-06-12T20:13:38+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-ai-head-discusses-companys-bold-strategy-to-shape-the-future-of-t-cell-therapies-at-longwood-spring-mit-conference/ 2024-06-18T23:14:53+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-announces-publication-of-positive-phase-i-clinical-trial-results-for-tvgn-489-in-blood-advances/ 2024-06-25T21:10:02+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-files-registration-statement-for-previously-disclosed-securities-does-not-relate-to-any-previously-undisclosed-new-issuances-of-dilutive-securities/ 2024-06-26T17:29:21+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/ryan-saadi-congratulates-marc-benioff-on-receiving-the-yale-legend-in-leadership-award-and-commends-yale-school-of-management-for-recognizing-the-importance-of-integrating-corporate-success-with-socia/ 2024-07-08T23:32:57+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bios-rd-leadership-discusses-the-promise-of-its-genetically-unmodified-off-the-shelf-t-cell-technology-for-the-treatment-of-infectious-diseases-cancers-and-neurological-disorders/ 2024-07-11T15:32:18+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-issues-letter-to-stockholders-highlighting-recent-achievements-growth-plans-and-consideration-of-a-potential-share-buyback/ 2024-07-11T17:07:16+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-seeks-advisor-for-capital-raise-before-exploring-options-for-lead-asset-ceo/ 2024-07-15T16:39:44+00:00 https://tevogenbio.com/wp-content/uploads/2024/07/logo-mergermarket.png https://tevogenbio.com/press-release/tevogen-bios-founding-ceo-ryan-saadi-expresses-conviction-in-companys-growth-strategy-and-reaffirms-newly-effective-form-s-1-does-not-relate-to-previously-undisclosed-new-issuance/ 2024-08-09T20:59:45+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bios-innovation-and-public-health-advisory-board-chairperson-professor-sten-vermund-appointed-dean-of-the-university-of-south-florida-health-college-of-public-health/ 2024-08-14T13:27:17+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-reports-second-quarter-2024-financial-results-eliminates-doubt-about-companys-ability-to-continue-as-a-going-concern-eliminates-series-b-preferred-shares/ 2024-08-15T17:37:00+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-secures-6-million-series-c-preferred-stock-investment/ 2024-08-22T15:20:56+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-leadership-meets-members-of-u-s-congress-to-advocate-for-long-covid-patients-and-highlights-achievements-and-assets-as-a-blueprint-for-biotech-innovation/ 2024-09-24T16:36:14+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-highlights-promising-trial-data-as-ceo-leads-patient-advocacy-at-capitol-hill-pledging-to-leverage-multi-billion-dollar-company-assets-to-combat-long-covid-and-spearhead-a-new-wave-of-med/ 2024-10-09T16:29:44+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-extends-pipeline-prioritizing-oncology-and-long-covid/ 2024-10-12T21:04:26+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/wp-content/uploads/2024/10/Pipline-for-PR.png https://tevogenbio.com/press-release/tevogen-bio-plans-to-share-1b-revenue-potential-of-its-pipeline-portfolio-beginning-week-of-october-14-2024/ 2024-10-12T21:26:27+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-ceo-reaffirms-the-companys-commitment-to-closing-the-information-gap-on-its-multi-billion-dollar-assets-following-the-release-of-revenue-projections/ 2024-10-14T22:59:17+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-takes-lead-in-developing-cell-therapies-designed-to-eradicate-post-procedure-human-papilloma-virus-in-women-with-precancerous-cervical-lesions/ 2024-10-15T19:25:31+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-ceo-expresses-gratitude-for-unprecedented-public-support-of-companys-business-model-of-commercial-success-through-patient-accessibility-and-reaffirms-his-commitment-to-share-additiona/ 2024-10-21T20:11:56+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-provides-clarity-on-cso-share-sales-to-satisfy-tax-obligations-expects-additional-forecast-and-progress-updates-in-the-coming-days/ 2024-10-21T20:13:58+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-specialty-care-reports-top-line-revenue-forecast-of-nearly-1-billion-in-launch-year-and-cumulative-5-year-estimate-between-18-billion-and-22-billion/ 2024-10-21T20:41:03+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-to-provide-timelines-associated-with-recently-announced-revenue-forecast-and-updates-on-operational-readiness-this-week/ 2024-10-23T18:54:44+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bios-effort-in-artificial-intelligence-tevogen-ai-joins-microsoft-for-startups-begins-accelerating-drug-development/ 2024-10-23T19:15:47+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-signs-letter-of-intent-with-cd8-technology-to-build-up-to-a-50-million-r-no-impact-on-shareholder-equity/ 2024-10-29T16:52:24+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-reports-nasdaq-listing-compliance-as-ceo-reaffirms-his-commitment-in-bridging-the-information-gap-about-the-company/ 2024-10-29T19:57:21+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-expands-on-microsoft-partnership-to-integrate-machine-learning-and-ai-into-preclinical-processes-accelerating-drug-development-and-reducing-costs/ 2024-10-31T15:12:29+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-announces-appointment-of-anthony-tarantino-as-patient-advocate-to-enhance-community-engagement-and-patient-support/ 2024-11-04T22:02:36+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-leverages-microsoft-partnership-to-deliver-machine-learning-based-target-identification-to-address-human-papilloma-virus-hpv-advancing-tvgn-920/ 2024-11-05T14:43:07+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-ceo-dr-ryan-saadi-expresses-gratitude-for-prestigious-roi-nj-recognition-highlighting-companys-novel-business-model-as-key-to-sustainable-success-through-patient-affordability/ 2024-11-05T22:06:24+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-nears-finalization-of-agreement-to-enhance-r-36-million-line-of-credit-available-for-continued-operations/ 2024-11-08T20:43:26+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-highlights-the-publication-of-promising-trial-data-as-the-ceo-expresses-optimism-about-the-companys-scientific-breakthrough-in-mainstreaming-cell-therapy-through-a-new-class-of-of/ 2024-11-12T00:31:13+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-reports-third-quarter-2024-financial-results-highlights-significantly-improved-financial-position-unreported-asset-value-on-balance-sheets-efficient-business-model/ 2024-11-19T23:25:30+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-ceo-reflects-on-public-support-reaffirms-preserving-shareholder-value-remains-his-priority-and-reinforces-options-including-a-potential-share-buyback-to-support-company-value/ 2024-11-27T14:17:46+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-prepares-organizational-readiness-to-support-companys-growth-strategy/ 2024-11-27T14:24:56+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/dr-ryan-saadi-commends-individuals-who-dedicate-time-to-public-service-and-congratulates-mayor-victor-sordillo-on-his-induction-into-the-nj-league-of-municipalities-hall-of-fame/ 2024-12-05T18:13:45+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-to-attend-the-43rd-annual-j-p-morgan-healthcare-conference/ 2024-12-11T19:44:50+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-to-host-panel-pioneering-the-economics-of-health-balancing-access-and-outcomes-during-the-43rd-annual-j-p-morgan-healthcare-conference/ 2024-12-19T00:28:48+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-strengthens-robust-ip-portfolio-with-filing-of-predictive-ai-patent-with-the-goal-to-establish-a-blueprint-to-unlock-the-full-potential-of-t-cell-therapies-and-accelerate-ai-integration-t/ 2024-12-19T14:21:09+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-to-host-panel-ai-in-biopharma-next-frontier-of-medical-innovation-during-the-43rd-annual-j-p-morgan-healthcare-conference/ 2024-12-23T23:29:29+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-to-host-panel-discussions-ai-in-biopharma-next-frontier-of-medical-innovation-and-pioneering-the-economics-of-health-balancing-access-and-outcomes-dur/ 2024-12-26T17:39:52+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-highlights-the-future-of-ai-driven-drug-development-in-fireside-chat-with-microsoft-during-the-j-p-morgan-healthcare-conference/ 2025-01-24T22:16:26+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-broadens-relationship-with-microsoft/ 2025-01-24T22:53:09+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-ceo-congratulates-lynne-patton-on-being-appointed-deputy-assistant-to-the-president-and-director-of-minority-outreach/ 2025-01-30T17:51:48+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/wp-content/uploads/2025/01/Lynne-Patton-and-Trump.png https://tevogenbio.com/press-release/agreement-to-receive-up-to-10-million-of-non-dilutive-grant-funding/ 2025-01-30T18:22:02+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-meets-barda-techwatch-team-highlighting-exactcell-technologys-potential-as-a-scalable-medical-countermeasure/ 2025-02-07T20:46:13+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bios-business-model-addresses-biopharma-industry-challenges-with-cost-efficient-innovation/ 2025-02-11T15:38:30+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-ceo-congratulates-rfk-jr-on-his-confirmation-as-secretary-of-the-hhs-echoes-commitment-to-innovation-and-affordability-for-americans/ 2025-02-14T16:51:56+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-ceo-addresses-short-selling-and-its-potential-impact-on-the-nations-health-and-prosperity/ 2025-02-14T17:14:14+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-shares-2024-financing-activity-on-one-year-anniversary-of-becoming-a-publicly-listed-company-highlights-operational-efficiency/ 2025-02-14T18:14:14+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bios-first-trading-year-efficiency-600-higher-market-cap-per-team-member-79-insider-owned/ 2025-02-21T23:06:00+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-oncology-reports-top-line-revenue-forecast-of-1-billion-in-launch-year-and-cumulative-5-year-estimate-between-10-billion-and-14-billion-forecasts-for-non-oncology-therapeutic-areas-to/ 2025-02-26T18:11:05+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-founder-and-ceo-dr-ryan-saadi-named-to-2025-njbiz-power-100-celebrating-innovation-and-leadership-in-accessible-t-cell-therapy/ 2025-02-28T18:19:25+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-to-receive-8-million-of-non-dilutive-grant-funding-reiterates-efficient-operations/ 2025-03-03T18:34:04+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bios-cio-head-of-tevogen-ai-mittul-mehta-featured-speaker-at-proskauers-ai-discussion-panel/ 2025-03-07T21:08:35+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-announces-unique-t-cell-vaccine-under-development-and-files-patent-with-the-uspto/ 2025-03-10T16:19:25+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-bio-appoints-david-e-banko-as-global-head-of-government-affairs-and-patient-access-advances-commercialization-plan/ 2025-03-25T17:22:09+00:00 https://tevogenbio.com/wp-content/uploads/2025/03/Tevogen-Logo-website.png https://tevogenbio.com/wp-content/uploads/2025/03/David-E-Banko.png https://tevogenbio.com/press-release/tevogen-bio-ceo-named-to-njbiz-2025-health-care-power-list-as-company-advances-commercialization-reaffirms-timeframe-on-previously-announced-forecast/ 2025-03-26T22:08:10+00:00 https://tevogenbio.com/wp-content/uploads/2025/03/Tevogen-Logo-website.png https://tevogenbio.com/press-release/tevogen-announces-tevogen-generics-a-new-effort-in-support-of-president-trumps-initiative-to-encourage-pharmaceutical-manufacturing-in-united-states/ 2025-04-09T21:12:34+00:00 https://tevogenbio.com/wp-content/uploads/2025/03/Tevogen-Logo-website.png https://tevogenbio.com/press-release/tevogen-bio-cio-and-head-of-tevogen-ai-presented-at-ai-x-bio-philly-event-showcasing-phillys-leading-ai-biotechs/ 2025-04-09T21:12:59+00:00 https://tevogenbio.com/wp-content/uploads/2025/03/Tevogen-Logo-website.png https://tevogenbio.com/press-release/tevogen-bio-highlights-most-recent-insider-ownership-of-74-management-maintains-conviction-in-the-companys-mission/ 2025-04-09T21:14:34+00:00 https://tevogenbio.com/wp-content/uploads/2025/03/Tevogen-Logo-website.png https://tevogenbio.com/press-release/tevogen-ceo-to-join-dialogue-on-paths-to-liquidity-strategies-for-adapting-to-a-volatile-market-at-bionjs-fifteenth-annual-bio-partnering-conference-with-experts-from-j-p-morgan-rsm-and-c/ 2025-04-14T19:03:15+00:00 https://tevogenbio.com/press-release/tevogen-bio-commissions-databricks-to-accelerate-development-of-predictcell-a-precision-ai-tool-for-target-prediction/ 2025-04-17T19:56:53+00:00 https://tevogenbio.com/press-release/tevogen-bio-finalizes-agreement-for-companys-own-cell-therapy-production-facility/ 2025-04-17T19:57:32+00:00 https://tevogenbio.com/press-release/tevogen-bio-announces-2025-annual-meeting/ 2025-04-26T01:12:57+00:00 https://tevogenbio.com/press-release/tevogen-reaffirms-oncology-top-line-revenue-forecast-of-1-billion-in-launch-year-and-cumulative-5-year-estimate-between-10-billion-and-14-billion/ 2025-04-28T20:48:37+00:00 https://tevogenbio.com/press-release/tevogen-informs-public-shareholders-about-drs-accounts-and-differences-to-brokerage-accounts/ 2025-04-30T18:34:47+00:00 https://tevogenbio.com/press-release/tevogen-ceo-to-join-dialogue-on-paths-to-liquidity-strategies-for-adapting-to-a-volatile-market-at-bionjs-fifteenth-annual-bio-partnering-conference-with-experts-from-j-p-morgan-rsm-and-c-2/ 2025-04-30T18:35:05+00:00 https://tevogenbio.com/press-release/cd8-technology-signs-letter-of-intent-for-tevogen-bios-in-house-manufacturing-facility-marking-first-phase-of-up-to-50-million-commitment/ 2025-04-30T19:42:57+00:00 https://tevogenbio.com/press-release/tevogen-to-share-direct-registration-system-drs-process-details-following-increased-shareholder-interest/ 2025-05-02T19:55:21+00:00 https://tevogenbio.com/press-release/tevogen-bios-business-model-addresses-biopharma-industry-challenges-with-cost-efficient-innovation-2/ 2025-05-12T20:25:43+00:00 https://tevogenbio.com/press-release/tevogen-to-update-on-robust-portfolio-assets-business-expansion-partnerships-limited-tradable-float-high-insider-ownership-and-strong-investor-confidence-ahead-of-june-23-annual-meeting/ 2025-05-22T17:33:10+00:00 https://tevogenbio.com/press-release/tevogen-bio-plans-to-expand-specialty-care-pipeline-to-include-patients-65-building-on-previous-forecast-of-nearly-1-billion-in-launch-year-updated-rnpv-to-follow/ 2025-05-23T20:36:55+00:00 https://tevogenbio.com/press-release/tevogen-bio-provides-additional-guidance-on-introduction-of-t-cell-therapy-for-oncology-and-specialty-care-therapeutic-areas/ 2025-05-27T16:44:52+00:00 https://tevogenbio.com/press-release/tevogen-details-its-artificial-intelligence-initiative-tevogen-ai-proprietary-ai-powered-immunotherapy-with-microsoft-and-databricks-partnerships/ 2025-05-30T18:52:40+00:00 https://tevogenbio.com/press-release/tevogen-investors-congratulate-on-prestigious-recognition-of-pioneering-biopharma-business-model-breakthrough-innovations-building-assets-estimated-to-exceed-10-billion/ 2025-06-06T20:45:59+00:00 https://tevogenbio.com/press-release/tevogen-expands-headquarters-amid-growth-of-ai-and-generics-biosimilars-initiatives/ 2025-06-17T15:01:08+00:00 https://tevogenbio.com/wp-content/uploads/2025/06/Tevogen-Warren-HQ.png https://tevogenbio.com/press-release/tevogen-updates-on-development-of-ebv-specific-t-cell-therapy-with-support-from-ai-powered-target-discovery/ 2025-06-18T13:28:45+00:00 https://tevogenbio.com/press-release/tevogen-ceo-contributes-to-build-out-and-first-year-operations-of-new-headquarters/ 2025-07-01T15:44:33+00:00 https://tevogenbio.com/press-release/tevogens-new-headquarters-fully-funded-by-ceo-centralizes-rd-and-ai-teams-to-accelerate-innovation/ 2025-07-10T19:00:26+00:00 https://tevogenbio.com/wp-content/uploads/2025/07/Warren-Collage.png https://tevogenbio.com/press-release/tevogen-ai-builds-alpha-version-of-predictcell-model-with-microsoft-and-databricks-observes-drastic-time-reduction-in-target-analysis-translating-to-potential-savings-of-billions-in-drug-development/ 2025-07-14T13:28:45+00:00 https://tevogenbio.com/press-release/tevogen-ai-targets-faster-time-to-market-with-ai-powered-patient-matching-following-predictcell-alpha-launch/ 2025-07-16T15:58:25+00:00 https://tevogenbio.com/press-release/tevogen-signs-letter-of-intent-for-new-in-house-cell-therapy-manufacturing-facility/ 2025-07-18T16:09:16+00:00 https://tevogenbio.com/wp-content/uploads/2025/07/lab-collage.png https://tevogenbio.com/press-release/tevogen-ai-receives-international-patent-publication-for-ai-technology-predicting-immunologically-active-peptides/ 2025-07-18T16:21:39+00:00 https://tevogenbio.com/press-release/tevogen-ai-applauds-u-s-governments-ai-action-plan-reaffirms-commitment-to-accelerating-ai-innovation-in-healthcare/ 2025-07-28T16:58:14+00:00 https://tevogenbio.com/press-release/tevogen-highlights-74-insider-ownership-reinforcing-long-term-vision/ 2025-07-30T17:37:17+00:00 https://tevogenbio.com/press-release/tevogen-bio-to-accept-1-million-additional-grant-funding-for-ai-expansion/ 2025-08-01T20:27:11+00:00 https://tevogenbio.com/press-release/tevogen-ceo-affirms-strong-growth-capital-position-and-ai-expansion-in-letter-to-stockholders/ 2025-08-01T20:37:31+00:00 https://tevogenbio.com/press-release/tevogen-ai-expands-collaboration-with-databricks-and-microsoft-to-build-the-beta-version-of-its-predictcell-model-with-a-focus-on-oncology/ 2025-08-05T18:49:24+00:00 https://tevogenbio.com/press-release/tevogen-receives-1-million-to-accelerate-ai-driven-drug-discovery-remains-well-capitalized-to-execute-growth-strategy/ 2025-08-07T13:35:07+00:00 https://tevogenbio.com/press-release/tevogen-sees-significant-institutional-ownership-growth-73-of-holders-increase-positions/ 2025-08-07T13:35:38+00:00 https://tevogenbio.com/press-release/repeat-tevogen-sees-significant-institutional-ownership-growth-73-of-holders-increase-positions/ 2025-08-13T19:19:47+00:00 https://tevogenbio.com/press-release/repeat-tevogen-ceo-affirms-strong-growth-capital-position-and-ai-expansion-in-letter-to-stockholders/ 2025-08-13T21:57:29+00:00 https://tevogenbio.com/press-release/repeat-tevogen-bio-oncology-reports-top-line-revenue-forecast-of-1-billion-in-launch-year-and-cumulative-5-year-estimate-between-10-billion-and-14-billion-forecasts-for-non-oncology-therapeutic/ 2025-08-13T22:12:46+00:00 https://tevogenbio.com/press-release/repeat-tevogen-bio-specialty-care-reports-top-line-revenue-forecast-of-nearly-1-billion-in-launch-year-and-cumulative-5-year-estimate-between-18-billion-and-22-billion/ 2025-08-13T22:32:06+00:00 https://tevogenbio.com/press-release/tevogen-bio-reaffirms-investor-confidence-with-estimated-asset-value-exceeding-10-billion/ 2025-08-13T22:41:31+00:00 https://tevogenbio.com/press-release/repeat-tevogen-ai-expands-collaboration-with-databricks-and-microsoft-to-build-the-beta-version-of-its-predictcell-model-with-a-focus-on-oncology/ 2025-08-13T22:51:37+00:00 https://tevogenbio.com/press-release/tevogen-to-release-internal-asset-valuation-ceo-affirms-assets-are-fully-protected/ 2025-08-14T20:18:50+00:00 https://tevogenbio.com/press-release/tevogen-ceo-donates-personal-shares-to-support-brain-injury-recovery/ 2025-08-18T23:01:21+00:00 https://tevogenbio.com/press-release/tevogen-ceo-donates-personal-shares-to-support-local-law-enforcement/ 2025-08-20T19:31:47+00:00 https://tevogenbio.com/press-release/tevogen-delivers-stronger-second-quarter-and-first-half-2025-financial-results-with-reduced-expenses-and-growth-momentum/ 2025-08-20T19:53:05+00:00 https://tevogenbio.com/press-release/repeat-tevogen-bio-enters-into-agreement-for-up-to-50-million-in-financing-to-advance-rd-and-clinical-development-efforts/ 2025-08-20T19:53:33+00:00 https://tevogenbio.com/press-release/tevogen-recognized-in-binjes-best-health-care-2025-for-advancing-health-equity-and-sustainable-biopharma/ 2025-08-22T20:19:25+00:00 https://tevogenbio.com/press-release/tevogen-sees-continued-growth-in-institutional-ownership-in-q2-2025-72-of-holders-increased-or-maintained-positions/ 2025-08-27T19:09:35+00:00 https://tevogenbio.com/press-release/tevogen-expresses-gratitude-to-yale-for-recognition-of-dr-ryan-saadi-and-companys-mission-of-health-equity/ 2025-08-27T19:15:00+00:00 https://tevogenbio.com/wp-content/uploads/2025/08/Yale-Saadi-IPO-Recognition.png https://tevogenbio.com/press-release/tevogen-bio-highlights-proprietary-assets-and-upcoming-valuation-disclosure/ 2025-08-27T19:19:48+00:00 https://tevogenbio.com/press-release/tevogen-underscores-the-importance-of-precision-immunotherapies-including-tvgn-489-for-vulnerable-individuals-infected-with-sars-cov-2/ 2025-09-08T18:47:34+00:00 https://tevogenbio.com/press-release/tevogen-shares-valuation-of-key-assets-and-potential-forecast-for-pipeline-product-focused-on-ebv-associated-leukemia-and-lymphomas/ 2025-09-08T19:18:45+00:00 https://tevogenbio.com/press-release/tevogen-values-tvgn-489-at-9-11-billion-rnpv-its-first-clinical-product-from-the-proprietary-exactcell-allogeneic-t-cell-platform/ 2025-09-08T19:35:24+00:00 https://tevogenbio.com/press-release/tevogen-estimates-5-year-top-line-revenue-of-%e2%88%bc6-5-billion-for-product-focused-on-liver-cancer-prevention-with-high-risk-chronic-hepatitis-b-infection/ 2025-09-09T19:29:56+00:00 https://tevogenbio.com/press-release/tevogen-cio-and-head-of-tevogen-ai-mittul-mehta-to-join-startup-forum-panel-at-databricks-data-ai-world-tour-in-boston/ 2025-09-19T19:31:11+00:00 https://tevogenbio.com/press-release/tevogen-commends-hhs-for-addressing-long-covid-emphasizes-tvgn-489s-potential-impact-for-20-million-americans/ 2025-09-19T19:39:41+00:00 https://tevogenbio.com/press-release/tevogen-marks-major-milestone-in-its-ai-initiative-to-enhance-efficacy-of-t-cell-based-therapies-with-100x-predictcell-beta-data-expansion/ 2025-10-03T17:36:18+00:00 https://tevogenbio.com/press-release/tevogen-updates-on-tvgn-489-following-growing-long-covid-patient-interest/ 2025-10-20T17:37:34+00:00 https://tevogenbio.com/press-release/tevogen-highlights-potential-role-of-tvgn-489-in-eliminating-persistent-viral-reservoirs-linked-to-long-covid/ 2025-10-24T18:47:00+00:00 https://tevogenbio.com/wp-content/uploads/2025/10/TVGN-489-Viral-Reservoir.png https://tevogenbio.com/press-release/tevogen-senior-management-engages-with-business-and-community-leaders-and-highlights-recent-progress/ 2025-10-30T16:04:13+00:00 https://tevogenbio.com/press-release/tevogen-clarifies-reported-financials-highlighting-strong-capital-efficiency-and-low-cash-burn/ 2025-11-04T19:31:47+00:00 https://tevogenbio.com/press-release/tevogen-reports-major-clinical-milestone-expands-hla-coverage-of-its-investigational-precision-t-cell-therapy-for-acute-and-long-covid/ 2025-11-05T20:31:11+00:00 https://tevogenbio.com/press-release/tevogen-highlights-continued-capital-efficiency-following-filing-of-q3-2025-form-10-q/ 2025-12-12T16:33:04+00:00 https://tevogenbio.com/press-release/tevogen-recognized-on-2025-njbiz-power-list-amid-growth-and-multi-billion-dollar-revenue-outlook/ 2025-12-12T16:36:44+00:00 https://tevogenbio.com/press-release/tevogen-ceo-supports-local-law-enforcement-with-personal-contribution-of-230000-companys-shares-of-common-stock/ 2025-12-12T17:09:00+00:00 https://tevogenbio.com/wp-content/uploads/2025/12/Warren-PD.jpg https://tevogenbio.com/press-release/tevogen-celebrates-board-member-dr-curtis-patton-honored-by-yale-university-for-distinguished-career-and-lasting-contributions-to-medical-education-and-equity-in-medicine/ 2025-12-12T17:09:18+00:00 https://tevogenbio.com/press-release/tevogen-ceo-donates-personal-shares-to-support-local-fire-department/ 2025-12-22T18:21:37+00:00 https://tevogenbio.com/wp-content/uploads/2025/12/Ryan-Board-Room.png https://tevogenbio.com/press-release/tevogen-ceo-donates-shares-to-support-education-for-underprivileged-children/ 2025-12-22T18:27:25+00:00 https://tevogenbio.com/wp-content/uploads/2025/12/Ryan-Board-Room-B.png https://tevogenbio.com/press-release/tevogen-demonstrates-platform-scalability-and-multi-indication-t-cell-pipeline-expansion-in-2025/ 2026-01-15T17:17:18+00:00 https://tevogenbio.com/press-release/tevogen-board-to-evaluate-potential-one-time-special-cash-dividend-to-shareholders/ 2026-02-02T18:26:34+00:00 https://tevogenbio.com/press-release/tevogen-to-align-long-term-stock-based-incentive-program-with-company-milestones-including-revenue/ 2026-02-02T18:28:39+00:00 https://tevogenbio.com/press-release/tevogen-signs-letter-of-intent-to-evaluate-potential-acquisition-of-sciometrix-and-its-digital-care-management-platform-clinicus/ 2026-02-26T21:43:49+00:00 https://tevogenbio.com/press-release/update-tevogen-signs-letter-of-intent-to-evaluate-potential-acquisition-of-sciometrix-and-its-digital-care-management-platform-clinicus/ 2026-02-26T21:51:55+00:00 https://tevogenbio.com/press-release/tevogen-signs-letter-of-intent-to-evaluate-potential-acquisition-of-a-contract-research-organization/ 2026-03-10T17:45:05+00:00 https://tevogenbio.com/press-release/tevogen-announces-reverse-stock-split/ 2026-03-10T17:50:06+00:00 https://tevogenbio.com/wp-content/uploads/2026/03/Ownership-Pie.png https://tevogenbio.com/press-release/letter-to-shareholders-from-ceo-dr-ryan-saadi/ 2026-03-10T18:06:48+00:00 https://tevogenbio.com/press-release/tevogen-names-leadership-team-to-execute-diversified-growth-strategy/ 2026-03-10T18:10:04+00:00 https://tevogenbio.com/press-release/tevogen-ceo-dr-ryan-saadi-reaffirms-clinical-commitment-during-international-long-covid-awareness-month-highlights-synergies-of-new-leadership-team-and-digital-care-platform/ 2026-03-19T19:13:00+00:00 https://tevogenbio.com/press-release/tevogen-ai-reports-advancements-in-predictcell-beta-demonstrates-improved-precision-metrics-and-expands-proprietary-ai-infrastructure/ 2026-03-19T19:24:51+00:00 https://tevogenbio.com/press-release/tevogen-reaffirms-capital-discipline-as-lead-investor-maintains-holdings-and-company-limits-share-utilization/ 2026-03-19T19:28:38+00:00 https://tevogenbio.com/press-release/tevogen-cio-and-head-of-tevogen-ai-mittul-mehta-to-speak-at-microsoft-fabric-community-conference-fabcon-2026/ 2026-03-20T05:09:43+00:00 https://tevogenbio.com/press-release/tevogen-regains-compliance-with-nasdaq-minimum-bid-price-requirement/ 2026-04-08T16:32:27+00:00 https://tevogenbio.com/press-release/tevogen-advances-strategic-cro-evaluation-to-expand-clinical-research-delivery-capabilities-and-drive-revenue-growth/ 2026-04-08T16:36:30+00:00 https://tevogenbio.com/press-release/tevogen-ai-nears-completion-of-predictcell-training-initiates-commercial-readiness-and-debuts-internal-application-portal/ 2026-04-28T17:07:16+00:00 https://tevogenbio.com/wp-content/uploads/2026/04/predicTcell-interface-preview.png https://tevogenbio.com/press-release/tevogen-announces-3-million-private-investment-at-8-per-share-a-14-premium-from-latest-market-close/ 2026-05-12T15:50:41+00:00 https://tevogenbio.com/press-release/letter-to-shareholders-from-ceo-dr-ryan-saadi-2/ 2026-05-18T15:57:27+00:00 https://tevogenbio.com/press-release/tevogen-signs-letter-of-intent-to-evaluate-potential-acquisition-of-a-management-services-organization/ 2026-05-21T16:24:01+00:00 https://tevogenbio.com/press-release/tevogen-bio-ceo-reinforces-commitment-to-retention-of-equity-capital-and-long-term-vision/ 2026-05-26T18:33:20+00:00 https://tevogenbio.com/wp-content/uploads/2023/10/Tevogen-Logo-RGB-TM.svg https://tevogenbio.com/press-release/tevogen-advances-strategic-acquisition-initiatives-with-potential-to-support-approximately-100-million-in-combined-annual-revenue/ 2026-05-28T16:28:49+00:00 https://tevogenbio.com/press-release/tevogen-announces-formation-of-a-healthcare-services-initiative/ 2026-06-09T20:04:03+00:00 https://tevogenbio.com/wp-content/uploads/2026/06/William-Keane-Tag.png